Skip to main content
Clinical Trials/ISRCTN27510582
ISRCTN27510582
Completed
Phase 4

Delivering personalised care in the management of exacerbations of chronic obstructive pulmonary disease: a multi-centre randomised clinical trial

niversity of Oxford0 sites308 target enrollmentAugust 23, 2017

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Chronic obstructive pulmonary disease
Sponsor
niversity of Oxford
Enrollment
308
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 23, 2017
End Date
October 9, 2020
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Participant is willing and able to give informed consent for participation in the trial
  • 2\. Male or female, aged 40 years or above
  • 3\. Diagnosed with COPD (primary or secondary care diagnosis) with spirometric confirmation of airflow obstruction (FEV1/FVC ratio \<0\.7\)
  • 4\. A history of at least 1 exacerbation in the previous 12 months, requiring systemic corticosteroids and/or antibiotics
  • 5\. Current or ex\-smoker with at least a 10 pack year smoking history
  • 6\. In the opinion of the research staff, is able and willing to comply with all trial requirements

Exclusion Criteria

  • 1\. History of atopic childhood asthma
  • 2\. Current history of primary lung malignancy or current active pulmonary TB
  • 3\. Clinically relevant disease or disorder (past or present) which in the opinion of the investigator may either put the subject at risk because of participating in the study or may influence the results of the study or the subject’s ability to participate in the study
  • 4\. Any clinically relevant lung disease, other than COPD considered by the investigator to be the primary diagnosis. For example mild\-to\-moderate bronchiectasis is acceptable in addition to COPD unless the bronchiectasis is considered to be the primary diagnosis
  • 5\. An alternative cause for the increase in symptoms of COPD that are unrelated to an exacerbation such as:
  • 5\.1\. Suspicion or clinical evidence of pneumonia
  • 5\.2\. High probability and suspicion of pulmonary embolism
  • 5\.3\. Suspicion or clinical evidence of a pneumothorax
  • 5\.4\. Primary ischaemic event – ST or Non ST elevation myocardial infarct and left ventricular failure \[i.e. not an exacerbation of COPD]
  • 6\. A known allergy to the IMP (prednisolone), NIMP (doxycycline) or to any of the constituents of the placebo

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Delivering personalised care in the management of exacerbations of chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease.MedDRA version: 20.0Level: PTClassification code 10009033Term: Chronic obstructive pulmonary diseaseSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2017-001586-24-GBniversity of Oxford228
Completed
Not Applicable
A Personalised Integrated Care Approach for Service Organisations and Care Models for Patients with rheumatoid arthritis and cardiovascular comorbidityM05M06Seropositive rheumatoid arthritisOther rheumatoid arthritis
DRKS00013637Heinrich-Heine-Universität Düsseldorf30
Completed
Not Applicable
The Effect of Wearable Device-based Physical Activity Intervention among North Korean RefugeesEndocrine, nutritional and metabolic diseases
KCT0007999Korea University Anam Hospital70
Recruiting
Not Applicable
An attempt of individualized administration of thiopurine by measuring metabolites and metabolic enzyme activitiesulcerative colitis, Crohn&#39s disease
JPRN-UMIN000047053Kitasato University Kitasato Institute Hospital, Center for Advanced IBD Research and Treatment50
Recruiting
Not Applicable
Infrastructure and processes for optimized care of patients with chronic wounds - decentralized and close to regular care in BremeICD-10:E10.54E10.55E10.74E10.75E11.54E11.55E11.74E11.75E12.54E12.55E12.74E12.75E13.54E13.55E13.74E13.75E14.5E14.74E14.75I70.2I70.24I70.25I87.01I87.21L97I83.0I83.2L89.1019L89.2029L89.3039T21.2T21.3T22.2T22.3T23.2T23.3T24.20T24.21T24.3T25.20T25.21T25.3T29.2T29.3T0.2T30.3T31.T21.6T21.7T22.6T22.7T23.60T23.61T23.7T24.60T24.61T25.7T29.6T29.7T30.6T30.7T32.T79.2T79.3T87.4T89.01T89.02T89.03E10-E14I70I87L89T20-T32T79T89T87I83Diabetes mellitusAtherosclerosisOther disorders of veinsDecubitus ulcer and pressure areaBurns and corrosionsCertain early complications of trauma, not elsewhere classifiedComplications peculiar to reattachment and amputationVaricose veins of lower extremities
DRKS00028522Kassenärztliche Vereinigung Bremen (KVHB)760